• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

A case of acute respiratory distress syndrome associated with novel H1N1 treated with intravenous immunoglobulin G

tetano

Editor, Senior Moderator
J Microbiol Immunol Infect. 2011 Jan 18. [Epub ahead of print]
A case of acute respiratory distress syndrome associated with novel H1N1 treated with intravenous immunoglobulin G.
Chong JL, Sapari S, Kuan YC.
Source

Department of Medicine, Hospital Tengku Ampuan Afzan, Kuantan, Pahang, Malaysia.
Abstract

Influenza A "novel H1N1" with severe acute respiratory distress syndrome (ARDS) is a serious illness that poses a challenge to clinicians managing such cases. This case report reveals a patient with ARDS secondary to influenza A with deteriorating clinical status, who improved tremendously after intravenous immunoglobulin G (IV IgG). Patients with H1N1 associated with ARDS may be given a trial of IV IgG. More case reports and trials are required to ascertain the efficacy of IV IgG and the best dosage and timing of starting IV IgG in relation to antiviral therapy.

Copyright ? 2011. Published by Elsevier B.V.

PMID:
21524955
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/21524955
 
Back
Top Bottom